Actively Recruiting
Feasibility Nutritional Supplements for Muscle Growth in CP
Led by Universitaire Ziekenhuizen KU Leuven · Updated on 2026-05-05
5
Participants Needed
1
Research Sites
226 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to investigate the feasibility of a 10-week plan with a nutritional supplement (leucine) and to perform pilot analyses on the effect of leucine on macroscopic muscle morphology in children with cerebral palsy.
CONDITIONS
Official Title
Feasibility Nutritional Supplements for Muscle Growth in CP
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with spastic cerebral palsy by a neuro-pediatrician at the CP Reference Centre of University Hospital Leuven
- Unilateral or bilateral involvement
- Classified as level II or III on the Gross Motor Function Classification System (GMFCS)
- Medial gastrocnemius muscle volume at least 20% of the expected volume for age-matched typically developing children
You will not qualify if you...
- Presence of dyskinesia or ataxia
- Severe co-morbidities
- Botulinum toxin treatment within 10 months before assessment
- Previous orthopedic or neurosurgery
- Severe ankle deformities preventing fitting in test positions
- Ankle range of motion less than 30% of normal values
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
UZ Leuven
Leuven, Vlaams-Brabant, Belgium, 3000
Actively Recruiting
Research Team
I
Ineke Verreydt
CONTACT
L
Lauraine Staut
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here